Objective: To review the results of SLNB for patients with cSCC of the head and neck at the authors' institution. Prospective multicenter studies are needed to examine the role, utility and cost-effectiveness of SLNB for this population. Background: Limited data exist on sentinel lymph node biopsy (SLNB) for cutaneous squamous cell carcinoma (cSCC) of the head and neck. Our case series and the pooled analysis support the concept that SLNB can be performed for high risk cutaneous SCC. Pooling together patients from the present and previous studies (total 83 patients), we calculated an Odds Ratio of 2.76 (95% CI 1.2-6.5 p=0.02) of finding positive sentinel nodes for an increase in tumor size from 3 cm. The incidence of positive sentinel nodes in previous reports ranged between 12.5% and 44.4%. Sentinel node-negative patients showed no metastases at a median follow-up of 17 months (range: 6-64). We examined a consecutive series of high risk cutaneous SCC patients undergoing SLNB at our large dermatological hospital, and performed a literature review and pooled analysis of all published cases of SLNB for cutaneous SCC.Īmong the 22 clinically node-negative patients undergoing SLNB at our hospital, one patient (4.5%) showed a histologically positive sentinel node and developed recurrences during follow-up. Our aim was to introduce the concept of SLNB for patients with high risk cutaneous SCC. As a result, sentinel lymph node biopsy (SLNB) has been adopted during the last decade as a diagnostic staging method to intelligently identify patients who would benefit from formal selective. SLNB might allow the timely inclusion of high risk patients in more aggressive treatment protocols, sparing at the same time node-negative patients the morbidity of potentially unnecessary therapy. Approximately 7080 of patients with cT1-2N0 oral squamous cell carcinoma (OSCC) ultimately prove to have no cancer in the cervical lymphatics on final pathology after selective neck dissection. However, there are subgroups of patients at higher risk, for whom sentinel lymph node biopsy (SLNB) might be useful. Methods: The PubMed database was searched for studies published before October 31, 2012. The metastatic potential is generally low. Background: The purpose of this study was to evaluate the efficacy of sentinel lymph node biopsy (SLNB) in early head and neck squamous cell carcinoma (HNSCC). Sentinel lymph node biopsy has been reported in case series of patients with head and. Cutaneous squamous cell carcinoma (SCC) is the second most common skin cancer. When should sentinel node biopsy be used for cutaneous squamous cell carcinoma Problem: Cutaneous squamous cell carcinoma (cSCC) is a common malignancy, accounting for 20 of all skin malignancies 1 furthermore, 80-90 of cSCC are located on thehead or neck 2. Squamous Cell Carcinoma (SCC) is associated with a more aggressive.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |